Table 1 Breast cancer characteristics and outcomes 22.4 y post-operation for 18 survivors and 18 non-survivors
SURVIVORS (invasive, n = 15: in situ, n = 3) | NON-SURVIVORS (invasive n = 18) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Alive and well | Death from “Disseminated breast cancer” | ||||||||||
Age at surgery (yrs) | Post-op follow-up survival (yrs) | Cancer size (mm) | Cancer “grade” | Involved lymph nodes | Nottingham prognostic Index | Age at surgery (yrs) | Post-op follow-up survival (yrs) | Cancer size (mm) | Cancer “grade” | Involved lymph nodes | Nottingham prognostic index |
54.15 | 15.39 | 15 | 2 | 1 | 4.30 | 41.87 | 0.76 | 120 | 3 | 2 | 7.40 |
40.84 | 19.12 | 50 | 1 | 0 | 3.00 | 46.46 | 1.16 | 21 | 3 | 4 | 6.42 |
36.48 | 19.39 | 80 | 3 | 0 | 5.60 | 39.61 | 1.90 | 40 | 3 | 2 | 5.80 |
41.68 | 19.93 | 20 | 3 | 0 | 4.40 | 37.83 | 2.28 | 15 | 3 | 0 | 4.30 |
32.70 | 20.32 | * | 3 | 0 | In situ | 56.57 | 2.50 | 20 | 3 | 5 | 6.40 |
40.08 | 20.50 | 8 | 2 | 0 | 3.16 | 26.90 | 2.69 | 20 | 3 | 1 | 5.40 |
37.50 | 20.67 | 28 | 3 | 0 | 4.56 | 43.78 | 4.21 | 18 | 2 | 0 | 3.36 |
34.23 | 21.04 | 35 | 2 | 0 | 3.70 | 28.07 | 5.43 | 19 | 2 | 0 | 3.38 |
42.97 | 21.96 | * | - | 0 | In situ | 38.45 | 5.60 | 30 | 3 | 1 | 5.60 |
42.26 | 23.35 | * | - | 0 | In situ | 37.45 | 6.79 | 25 | 3 | 0 | 4.50 |
41.15 | 23.50 | 10 (?) | 3 | 0 | 4.20 | 43.69 | 8.01 | 30 | 1 | 1 | 3.60 |
36.76 | 24.08 | 35 | 2 | 0 | 3.70 | 39.22 | 8.07 | 30 | 3 | 1 | 5.60 |
34.80 | 24.38 | 20 | 3 | 0 | 4.40 | 40.73 | 8.46 | 15 | 2 | 0 | 3.30 |
32.47 | 24.83 | 8 | 3 | 0 | 4.16 | 44.02 | 9.32 | 15 | 2 | 0 | 3.30 |
34.84 | 25.04 | 30 | 3 | 0 | 4.60 | 42.43 | 13.11 | 45 | 3 | 1 | 5.90 |
35.98 | 25.41 | 40 | 3 | 0 | 4.80 | 38.46 | 15.73 | 8 | 2 | 0 | 3.16 |
38.03 | 26.19 | 57 | 2 | 0 | 4.15 | 31.75 | 21.16 | 10 | 3 | 0 | 4.20 |
34.08 | 28.14 | 10 | 3 | 0 | 4.20 | 34.59 | 22.82 | 15 | 3 | 0 | 4.30 |